Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic...
26 KB (2,420 words) - 02:40, 26 September 2024
infiltrative disorders such as sarcoidosis. Cetuximab is the first-line therapy for Ménétrier disease. Cetuximab is a monoclonal antibody against epidermal...
10 KB (1,083 words) - 21:10, 19 December 2024
drug cetuximab, and discovered that these individuals had IgE antibodies in their blood that were specifically targeted to the portion of cetuximab which...
37 KB (4,131 words) - 13:28, 31 December 2024
V600K mutation, as detected by an FDA-approved test; in combination with cetuximab, for the treatment of adults with metastatic colorectal cancer with a...
13 KB (1,054 words) - 21:06, 20 December 2024
the United States in December 2022 for lung cancer and together with Cetuximab in 2024 for colorectal cancer. Adagrasib is indicated for the treatment...
12 KB (768 words) - 22:07, 6 December 2024
Panitumumab (section Panitumumab vs. cetuximab)
the labels of two anti-EGFR monoclonal antibody drugs (panitumumab and cetuximab) indicated for the treatment of metastatic colorectal cancer to include...
16 KB (1,440 words) - 17:54, 12 December 2024
Allergic Facial nerve palsy Anti-cancer treatments such as erlotinib, cetuximab, and panitumumab, which block the function of EGFR (the epidermal growth...
3 KB (220 words) - 20:32, 27 August 2024
trial sought to compare the efficacy of Abituzumab, cetuximab, and irinotecan compared to cetuximab and irinotecan in patients with KRAS (exon 2) wild-type...
9 KB (974 words) - 19:52, 20 December 2023
FOLFIRI is often[citation needed] combined with bevacizumab, aflibercept, cetuximab or panitumumab to improve efficacy and response rate. In the short term...
4 KB (411 words) - 21:05, 6 May 2024
ErbB2) receptor expressed in some types of breast cancer Alemtuzumab Cetuximab target the epidermal growth factor receptor (EGFR). It is approved for...
20 KB (2,234 words) - 01:21, 22 July 2024
was predictive of a very poor response to panitumumab (Vectibix) and cetuximab (Erbitux) therapy in colorectal cancer. As of 2008, the most reliable...
45 KB (5,069 words) - 19:07, 15 December 2024
At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with the Food and Drug Administration...
17 KB (1,400 words) - 22:21, 10 September 2024
non-primate mammals, alpha-gal is also found in cat dander and in the drug cetuximab. Allergic reactions to alpha-gal usually occur 3–6 hours after consuming...
19 KB (2,273 words) - 20:32, 15 December 2024
advantage at three years was noted when cetuximab was given concurrently with radiation (bioradiation). Cetuximab trials were completed before knowledge...
233 KB (24,385 words) - 01:55, 12 December 2024
MAbs approved by the FDA for cancer include: Alemtuzumab Bevacizumab Cetuximab Dostarlimab Gemtuzumab ozogamicin Ipilimumab Nivolumab Ofatumumab Panitumumab...
48 KB (4,972 words) - 04:27, 21 December 2024
VTX-2337 is a selective TLR-8 agonist and together with monoclonal antibody cetuximab it was used as a potential therapy for the treatment of recurrent or metastatic...
75 KB (9,227 words) - 23:32, 16 October 2024
origin of the tumor cells. Various targeted agents, such as imatinib, cetuximab, gefitinib, trastuzumab, had been used for exploring new treatment for...
19 KB (1,998 words) - 07:13, 6 May 2024
Dalesio O, Punt CJ (February 2009). "Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer". N Engl J Med. 360 (6): 563–72. doi:10...
23 KB (646 words) - 02:35, 9 December 2024
of a drug depends on the genotype of a patient. For example, Erbitux (cetuximab) increases the survival rate of colorectal cancer patients if they carry...
33 KB (3,412 words) - 06:46, 16 December 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
73 KB (6,489 words) - 08:56, 21 December 2024
therapies used in head and neck cancers include cetuximab, bevacizumab, and erlotinib.[citation needed] Cetuximab is used for treating people with advanced-stage...
105 KB (11,717 words) - 05:55, 30 December 2024
cetrimide (INN) cetrimonium bromide (INN) cetrorelix (INN) Cetrotide cetuximab (INN) cetylpyridinium chloride (INN) Cevi-Bid cevimeline (INN) cevipabulin...
10 KB (490 words) - 05:49, 19 October 2024
Passive antibody therapy (section Cetuximab)
of these problems and were suitable for the clinical cancer treatment. Cetuximab (trade name: Erbitux ) is a recombinant chimeric monoclonal antibody designed...
27 KB (2,923 words) - 15:03, 4 April 2024
Examples of radiosensitizing drugs include cisplatin, nimorazole, and cetuximab. The impact of radiotherapy varies between different types of cancer and...
114 KB (13,666 words) - 16:00, 1 December 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
93 KB (8,733 words) - 03:33, 16 December 2024
EGFR C797S mutation if it is combined with an anti-EGFR antibody such as cetuximab or panitumumab. Brigatinib is an inhibitor of ALK and mutated EGFR. ALK...
10 KB (796 words) - 12:29, 5 August 2024
for human therapy include abciximab (ReoPro), basiliximab (Simulect), cetuximab (Erbitux), infliximab (Remicade) and rituximab (MabThera). There are also...
14 KB (1,787 words) - 23:05, 9 January 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
149 KB (15,719 words) - 16:46, 9 December 2024
marketed product is Erbitux (cetuximab), for which it has marketing rights worldwide, apart from North America. (Cetuximab was discovered by Imclone Systems...
48 KB (4,737 words) - 15:31, 2 December 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
121 KB (13,818 words) - 07:04, 26 December 2024